The CGM market is an exciting, fast-growing, multibillion-dollar medtech sector, according to our new Medtech Market ...

Medtronic (NYSE: MDT) announced that Gregory L. Smith, EVP, enterprise operations, notified the company of his decision to ...

The pharma company's newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that's proving to be the ...

An announcement from Medtronic ( ($MDT) ) is now available. On November 1, 2025, Medtronic announced the retirement of Gregory L. Smith, Executive ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...

Every product we touch has a footprint. A phone, a fridge, a hospital syringe. Each begins and ends in the same place: the ...

A Medtronic hypertension procedure that can provide last-resort treatment for a condition that affects nearly half of all U.S ...

National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...

Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment ...

Okay. Hello, everyone. Thanks for joining us today. I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thank you for joining call showcasing the Altaviva device, which ...

DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first ...

Medtronic PLC, a global leader in medical technology with a market capitalization of $119 billion, has been navigating a complex landscape of innovation, strategic initiatives, and market challenges.